Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Figure Technology Solutions Inc. Class A Common Stock (FIGR) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance

Figure Technology Solutions Inc. Class A Common StockTrade
uniQure N.V. Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Figure Technology Solutions Inc. Class A Common Stock vs uniQure N.V. Ordinary Shares — how do they compare? Figure Technology Solutions Inc. Class A Common Stock trades at $24.68 (market cap $6.11B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B). The key difference: Figure Technology Solutions Inc. Class A Common Stock is far larger — about 4.1× uniQure N.V. Ordinary Shares's market cap, and uniQure N.V. Ordinary Shares is trading nearer its 52-week high, Figure Technology Solutions Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Figure Technology Solutions Inc. Class A Common Stock for 6 Days and uniQure N.V. Ordinary Shares for 0 Days on average.

FIGRQURE
Market Cap
$6.11B$1.48B
Volume
5,025,6042,488,780
Sector
FinancialsHealth
52-Week High
$73.91$70.59
52-Week Low
$24.91$9.03
Typical Hold Time
6 Days0 Days
Enterprise Value
$6.15B$728.62M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Figure Technology Solutions Inc. Class A Common Stock

FIGR trades at $27.25, down 4.25% over 24 hours, with a bearish technical signal from moving averages. The company reported strong fundamentals: Q2 2026 EPS beat expectations at $0.37, revenue grew to $509.30M in 2025, and net income margin improved to 33.83% in 2026. Recent news highlights the Kiavi acquisition and partnership with Sierra to enhance AI-driven lending capabilities, supporting growth in loan volumes.

Wall Street maintains a bullish outlook with a consensus price target of $50.00, implying significant upside. However, risks include recent earnings misses in Q4 2025 and Q1 2026, negative operating cash flow projected for 2026, and competitive pressures in the lending infrastructure space. The stock's high P/E of 28.52 warrants caution amid growth execution uncertainties.

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FIGR

No sentiment data available yet.

QURE
100% Buy0% Sell
Avg holding period · 0 Days

About Figure Technology Solutions Inc. Class A Common Stock

Figure Technology Solutions operates a blockchain-native capital marketplace. Its platform supports loan origination, funding, sale, and trading of tokenized assets, along with digital-asset infrastructure and services.

Read more on FIGR →

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →